Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of orelabrutinib in adults with primary immune thrombocytopenia is underway, with results not yet di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Orelabrutinib (orelabrutinib)

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Primary Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN